Adaptive immune responses to SARS-CoV-2
- 1 May 2021
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 172, 1-8
- https://doi.org/10.1016/j.addr.2021.02.009
Abstract
No abstract availableKeywords
Funding Information
- University of California Irvine
This publication has 100 references indexed in Scilit:
- MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Emerging Infectious Diseases, 2017
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human PrimatesACS Infectious Diseases, 2016
- Fc receptors in antibody‐dependent enhancement of viral infectionsImmunological Reviews, 2015
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteinsBiochemical and Biophysical Research Communications, 2014
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infectionArchiv für die gesamte Virusforschung, 2013
- Antibody-Dependent Enhancement Occurs Upon Re-Infection with the Identical Serotype Virus in Feline Infectious Peritonitis Virus InfectionThe Journal of Veterinary Medical Science, 2008
- Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndromeJournal of Clinical Virology, 2005
- Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirusClinical Microbiology & Infection, 2004
- Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS CoronavirusClinical and Vaccine Immunology, 2004
- RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILANDAmerican Journal of Epidemiology, 1984